WWW Get Quote NAVs News
Sign in if Registered User! | New to Sify? Click here
 
SENSEX
16042.18 0.00
NIFTY
4792.65 0.00
 
Feb 9, 4:05 PM
 
 
STOCKS LAST SEARCHED
   
IMAGEGALLERY
   
GOLD RATE
Rs. 16360.00
(10 gm)
Glitter Estimator
   
OTHER UTILITIES
Savings calculator | Retirement planner | Portfolio manager | Currency converter | Glitter estimator
Companies' quote in alphabetical order:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
 
Sify Home>>Finance>>Equity>>US nod for Aurobindo's Cefdinir capsules
Comments Share Print  Rate 
BUSINESS LINE

US nod for Aurobindo's Cefdinir capsules

2008-01-21 11:38:14
Last Updated: 2008-01-21 11:44:39
 

Mumbai: Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration to market its 300mg Cefdinir capsules in the US market.

The drug falls under the anti-bacterial segment and is a generic equivalent of Abbott Laboratories, 'OMNICEF'.

Earlier, the company also received the final approval for 125 mg/5 ml and 250 mg/5 ml oral suspension of this drug from the USFDA.

 Check out our Yearender Special

This is Aurobindo's 62nd ANDA approval from USFDA.

Comments Share Print  Rate 
 
 
Companies’ quote in alphabetical order:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Image Galleries

Sponsor Ads
Special Rate on Stock Products:
Intraday | Exclusive | Live stock chat | StreetCall | MultiBagger | NiftyTraders | MarketBuzz | SmarTrade
© Copyright Sify Technologies Ltd, 1998-2010. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer | Privacy Policy & Parental Guidance on pornography | careers@sify | About Us | Feedback | Advertise